These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14671565)

  • 1. [New guidelines of the Joint National Committee (USA) on Prevention, Diagnosis and Management of Hypertension. From JNC VI to JNC VII].
    Britov AN; Bystrova MM
    Kardiologiia; 2003; 43(11):93-7. PubMed ID: 14671565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine.
    Hyman DJ; Pavlik VN
    Arch Intern Med; 2000 Aug 14-28; 160(15):2281-6. PubMed ID: 10927724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain.
    Banegas JR; Segura J; Ruilope LM; Luque M; García-Robles R; Campo C; Rodríguez-Artalejo F; Tamargo J;
    Hypertension; 2004 Jun; 43(6):1338-44. PubMed ID: 15117908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between Joint National Committee-VI classification of hypertension and ambulatory blood pressure in patients with hypertension diagnosed by casual blood pressure.
    Inden Y; Tsuda M; Hayashi H; Takezawa H; Iino S; Kondo T; Yoshida Y; Akahoshi M; Terasawa M; Itoh T; Saito H; Hirai M
    Clin Cardiol; 1998 Nov; 21(11):801-6. PubMed ID: 9825191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatment for prehypertension: to treat or not to treat?
    Martin JF; Martin LN; Cipullo JP
    Recent Pat Cardiovasc Drug Discov; 2009 Jun; 4(2):133-41. PubMed ID: 19519555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of JNC VI: new directions in the management of hypertension and cardiovascular risk.
    Sheps SG
    Am J Hypertens; 1999 Aug; 12(8 Pt 2):65S-72S. PubMed ID: 10478699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicaid prescriber compliance with Joint National Committee VI Hypertension Treatment Guidelines.
    Clause SL; Hamilton RA
    Ann Pharmacother; 2002 Oct; 36(10):1505-11. PubMed ID: 12243597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proportion of US adults potentially affected by the 2014 hypertension guideline.
    Navar-Boggan AM; Pencina MJ; Williams K; Sniderman AD; Peterson ED
    JAMA; 2014 Apr; 311(14):1424-9. PubMed ID: 24682242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thinking beyond new clinical guidelines: update in hypertension.
    Griffin BR; Schinstock CA
    Mayo Clin Proc; 2015 Feb; 90(2):273-9. PubMed ID: 25659243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The problems of hypertension in the elderly.
    Arya SN
    J Indian Med Assoc; 2000 Apr; 98(4):176-9. PubMed ID: 11016181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New high blood pressure guidelines create new at-risk classification: changes in blood pressure classification by JNC 7.
    Miller ER; Jehn ML
    J Cardiovasc Nurs; 2004; 19(6):367-71; quiz 372-3. PubMed ID: 15529056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JNC-7 guidelines: are they still relevant?
    Cushman WC
    Curr Hypertens Rep; 2007 Nov; 9(5):380-6. PubMed ID: 18177584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rationale for differing national recommendations for the treatment of hypertension.
    Ramsay LE; Wallis EJ; Yeo WW; Jackson PR
    Am J Hypertens; 1998 Jun; 11(6 Pt 2):79S-88S; discussion 95S-100S. PubMed ID: 9655567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive therapy versus alternative therapeutic options for prehypertension: an evidence-based approach.
    Gaddam KK; Ventura H; Lavie CJ
    Future Cardiol; 2012 Jan; 8(1):115-22. PubMed ID: 22185450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical appraisal of the JNC VI, WHO/ISH and BHS guidelines for essential hypertension.
    O'Brien E; Staessen JA
    Expert Opin Pharmacother; 2000 May; 1(4):675-82. PubMed ID: 11249509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reclassification of Hypertensive Outpatients According to New US Guidelines on High Blood Pressure.
    Tocci G; Presta V; Figliuzzi I; Miceli F; Citoni B; Coluccia R; Paini A; Salvetti M; Ferrucci A; Muiesan ML; Volpe M
    Am J Hypertens; 2019 Jan; 32(1):77-87. PubMed ID: 30192909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertension: insights from the JNC-VI report.
    Kaplan NM
    Am Fam Physician; 1998 Oct; 58(6):1323-30. PubMed ID: 9803197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension management in 2002: where have we been? where might we be going?
    Hansson L
    Am J Hypertens; 2002 Oct; 15(10 Pt 2):101S-107S. PubMed ID: 12383590
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.